Phase 3 NSCLC (Non-small Cell Lung Cancer) trials recruiting now

All NSCLC (Non-small Cell Lung Cancer) trials, every phase

Other phases for NSCLC (Non-small Cell Lung Cancer)

Phase 3 NSCLC (Non-small Cell Lung Cancer) trials

• A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC
  NCT06617416 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study to Evaluate GFH375 Versus Docetaxel in Participants With Non-Small Cell Lung Cancer With KRAS G12D Mutation
  NCT07668752 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC
  NCT07016126 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
  NCT06881784 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 153 locations

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.